The formulation of lyophilized liposome cakes, micronization of the cake, aerosolization using a dry powder inhaler, and the in vitro distribution of such powders upon aerosolization in a silicone elastomer throat attached to an Andersen cascade impactor are reported. Two liposome compositions consisting of phosphatidylcholine/phosphatidylglycerol and phosphatidylcholine/cholesterol are examined. Fluorescent marker molecules, 5,6-carboxyfluorescein and N,N'-bis(1-hexlheptyl)-3,4:-9,10-perylene-bis (dicarboximide), are used to monitor directly the distribution of liposomal lipid upon aerosolization. The results demonstrate that milled micronized liposome powders can be effectively aerosolized at a fixed flow rate. The de-aggregation and dispersion of the liposome powder is not significantly improved by the addition of spray-dried lactose used as carrier powder
Formulation and In-Vitro Performance of Liposome Powder Aerosols
Schreier, H., Mobley, WC., Concessio, N., Hickey, A., & Niven, RW. (1994). Formulation and In-Vitro Performance of Liposome Powder Aerosols. STP Pharma Sciences, 4(1), 38-44.
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments
Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses